More on: Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: A randomized crossover trial [12]
10.1111/j.1538-7836.2006.01926.x
Saved in:
Main Authors: | Almsherqi, Z.A., Mclachlan, C.S., Sharef, S.M. |
---|---|
Other Authors: | PHYSIOLOGY |
Format: | Others |
Published: |
2016
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/131714 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
More on: Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: A randomized crossover trial [12]
by: Almsherqi, Z.A., et al.
Published: (2011) -
Optimal antiplatelet treatment for percutaneous coronary intervention: Clopidogrel vs. ticlopidine
by: Almsherqi, Z.A., et al.
Published: (2011) -
Optimal antiplatelet treatment for percutaneous coronary intervention: Clopidogrel vs. ticlopidine
by: Almsherqi, Z.A., et al.
Published: (2016) -
Non-bleeding side effects of clopidogrel: Have large multi-center clinical trials underestimated their incidence?
by: Almsherqi, Z.A., et al.
Published: (2011) -
Non-bleeding side effects of clopidogrel: Have large multi-center clinical trials underestimated their incidence?
by: Almsherqi, Z.A., et al.
Published: (2016)